Article Versions Notes

Shavit-Stein E, Gofrit SG, Gayster A, Teldan Y, Ron A, Abu Bandora E, Golderman V, Gera O, Harnof S, Chapman J, et al. Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule. Biomolecules. 2020; 10(11):1552. https://doi.org/10.3390/biom10111552

Shavit-Stein, Efrat, Shany Guly Gofrit, Alexandra Gayster, Yotam Teldan, Ariel Ron, Eiman Abu Bandora, Valery Golderman, Orna Gera, Sagi Harnof, Joab Chapman, and et al. 2020. "Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule" Biomolecules 10, no. 11: 1552. https://doi.org/10.3390/biom10111552

Shavit-Stein, E., Gofrit, S. G., Gayster, A., Teldan, Y., Ron, A., Abu Bandora, E., Golderman, V., Gera, O., Harnof, S., Chapman, J., & Dori, A. (2020). Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule. Biomolecules, 10(11), 1552. https://doi.org/10.3390/biom10111552